Menu
Shareholders | Shares | Votes (%) |
|---|---|---|
Total | 597 287 105 | 100,0 |
FÖRSÄKRINGSAKTIEBOLAGET AVANZA PENSION | 34 207 313 | 5,73 |
AILEEN JANE MCGETTRICK | 31 505 100 | 5,27 |
JULIE RICHARDS | 31 505 100 | 5,27 |
PAUL BRENDAN MONAGHAN | 31 505 100 | 5,27 |
STEVEN ANDREW ROSS | 31 505 100 | 5,27 |
NORDIC UNDERWRITING APS | 21 296 928 | 3,57 |
THE BANK OF NEW YORK MELLON, W9* | 11 253 728 | 1,88 |
TUVEDALEN LIMITED | 10 390 956 | 1,74 |
CARDEON AB (PUBL) | 9 350 000 | 1,57 |
JAN KARLSSON | 5 884 180 | 0,99 |
Total, 10 largest owners | 218 403 505 | 36,57 |
Other owners | 378 883 600 | 63,43 |
* Refers to the technology and development partner’s ownership (TTP, via management structure).
The company has outstanding warrants for management and board of 2,500,000 and employees of Psyros Diagnostics Ltd. of 5,370,000, which can result in a total of
7,870,000 shares and can thus cause dilution. As of January 2024, the company has outstanding warrants series TO7 of 108,756,747 options.
Prolight Diagnostics’ share is traded on the Nordic Growth Market, NGM SME, under the name PRLD.
Source: Euroclear
